Aldeyra Therapeutics, Inc.
ALDX
Health Care
1
exclusion reason
1 theme
This page is part of our public exclusion list — a transparency tool that shows which companies we screen out and why. It is not investment advice, and it is not an accusation. But it is subject to change as our understanding of the facts evolves.
Aldeyra Therapeutics, Inc. is a biotechnology company focused on developing treatments for immune-mediated and inflammatory diseases. As a pharmaceutical research and development firm, its preclinical and clinical testing processes inherently involve animal experimentation to evaluate drug safety and efficacy, a standard industry practice for regulatory approval. The company's business model is predicated on this research pathway.
This activity falls under the animal_exploitation exclusion as a commercial exploitation of animals not covered by a more specific child code. While the provided evidence from Cruelty Free Investors lists Aldeyra among companies that exploit animals, specific details on the scale, nature, or recency of its animal testing programs are not included in the gathered materials.
Research Sources
1 organization
Related Exclusions
Wondering what we do invest in?
The Naughty List
A digest of changes to our exclusion list — new additions, removals, and the evidence behind them. We review the list continuously as new evidence surfaces.
Companies appear on our exclusion list based on our investment judgment — not because they've done anything illegal. This is a difference of values and opinion, not an accusation of wrongdoing. Exclusion does not constitute a recommendation against investing in any company, and absence from the list does not constitute a recommendation to invest.
This information is provided for educational and transparency purposes only and should not be relied upon as investment advice. Data is drawn from independent watchdogs, NGOs, government registries, and Ethical Capital's ongoing research — see Research Sources for the full list.
Ethical Capital LLC is a state-registered investment adviser in Utah (CRD #316032). Registration does not imply a certain level of skill or training.